The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases, cardiovascular and metabolic diseases. Within Janssen talented, entrepreneurial people are working in a dynamic culture in which innovation and a 'can do' state of mind are the central points.
To combat and prevent infectious diseases Janssen has R&D facilities in Leiden (formerly known as Crucell) that focus on the discovery and development of vaccines using the PER.C6® cell line. Our relentless efforts in researching innovative vaccines make us a top-5 pharmaceutical R&D company, both in the Netherlands and worldwide.
The Janssen Infectious Diseases and Vaccines R&D organization and the Janssen Prevention Center employ around 700 people in The Netherlands. More information can be found through www.crucell.com.
Together, we dream of a world where people live longer, happier lives in good health, and we are determined to help make that dream a reality.